Conformational homogeneity in molecular recognition by proteolytic enzymes

Journal of Molecular Recognition

Volumn 12, Issue 6, 1999, Pages 363-370

  Tyndall, Joel D A ^a   Fairlie, David P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Conformation; Extended; Inhibitor; Protease; Strand; Substrate

Indexed keywords

ALPHA HELIX; BETA SHEET; CRYSTAL STRUCTURE; ENZYME BINDING; ENZYME CONFORMATION; ENZYME INHIBITOR; ENZYME SUBSTRATE; HYDROGEN BOND; PROTEIN FOLDING; PROTEIN HYDROLYSIS; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEINASE;

ANIMALS; ENDOPEPTIDASES; HYDROGEN BONDING; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; PROTEASE INHIBITORS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 0033226493     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1352(199911/12)12:6<363::AID-JMR478>3.0.CO;2-M     Document Type: Article

References (40)

1. Abad-Zapatero, C., Goldman, R. W., Muchmore, S. W., Hutchins, C., Stewart, K., Navaza, J., Payne, C. D. and Ray, T. L. (1996). Structure of a secreted aspartic protease from C. Albicans complexed with a potent inhibitor: implications for the design of antifungal agents. Protein Sci. 5, 640-652.
2. Abad-Zapatero, C., Goldman, R., Muchmore, S. W., Hutchins, C., Oie, T., Stewart, K., Cutfield, S. M., Cutfield, J. F., Foundling, S. I. and Ray, T. L. (1998). Structure of secreted aspartic proteinases from Candida. Implications for the design of antifungal agents. Adv. Exp. Med. Biol. 436, 297-313.
3. Abola, E. E., Sussman, J. L., Prilusky, J. and Manning, N. O. (1977). Protein data bank archives of three-dimensional macromolecular structures. In Methods in Enzymology Vol. 277, Carter Jr., C. W. and Sweet, R. M. (eds). Academic Press: San Diego; 556-571.
4. Becker, M. M., Harrop, S. A., Dalton, J. P., Kalinna, B. H., McManus, D. P. and Brindley, P. J. (1995). Cloning and characterization of the Schistosoma japonicum aspartic proteinase involved in hemoglobin degradation. J. Biol. Chem. 270(41), 24496-24501.
5. Bernstein, P. R., Edwards, P. D. and Williams, J. C. (1994). Inhibitors of human leukocyte elastase. Prog. Med. Chem. 31, 59-120.
6. Boycott, R., Klenk, H. D. and Ohuchi, M. (1994). Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology 203(2), 313-319.
7. Brindley, P. J., Kalinna, B. H., Dalton, J. P., Day, S. R., Wong, J. Y., Smythe, M. L. and McManus, D. P. (1997). Proteolytic degradation of host hemoglobin by schistosomes. Mol. Biochem. Parasitol. 89(1), 1-9.
8. Brinkworth, R. I., Fairlie, D. P., Leung, D. and Young, P. R. (1999). Homology model of the Dengue 2 virus NS3 protease: interactions with both substrate and NS2B cofactor. J. Gen. Virol. 80, 1167-1177.
9. Darke, P. L. and Huff, J. R. (1994). HIV protease as an inhibitor target for the treatment of AIDS. Adv. Pharmac. 25, 399-454.
10. Dauter, Z., Betzel, C., Hohne, W. E., Ingelman, M. and Wilson, K. S. (1988). Crystal structure of a complex between thermitase from Thermoactinomyces vulgaris and the leech inhibitor eglin. FEBS Letts 236(1), 171-178.
11. Dreyer, G. B., Metcalf, B. W., Tomaszek, T. A., Jr, Carr, T. J., Chandler, A. C. D., Hyland, L., Fakhoury, S. A., Magaard, V. W., Moore, M. L., Strickler, J. E., Debouck, C. and Meek, T. D. (1989). Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. Proc. Natl Acad. Sci. USA 86(24), 9752-9756.
12. Fath, M. A., Wu, X., Hileman, R. E., Linhardt, R. J., Kashem, M. A., Nelson, R. M., Wright, C. D. and Abraham, W. M. (1998). Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J. Biol. Chem. 273(22), 13563-13569.
13. Gibson, W. and Hall, M. R. (1997). Assemblin, an essential herpesvirus proteinase. Drug Des. Discov. 15(1), 39-47.
14. Glover, J. N. M. and Harrison, S. C. (1995). Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373, 257-261.
15. Grams, F., Reinemer, P., Powers, J. C., Kleine, T., Pieper, M., Tschesche, H., Huber, R. and Bode, W. (1995). X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur. J. Biochem. 228(3), 830-841.
16. Holden, H. M., Tronrud, D. E., Monzingo, A. F., Weaver, L. H. and Matthews, B. W. (1987). Slow-and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues. Biochemistry 26(26), 8542-8553.
17. Hoog, S. S., Zhao, B., Winborne, E., Fisher, S., Green, D. W., DesJarlais, R. L., Newlander, K. A., Callahan, J. F., Moore, M. L. and Huffman, W. F. et al. (1995). A check on rational drug design: crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel gamma-turn mimetic inhibitor. J. Med. Chem. 38(17), 3246-3252.
18. Hugli, T. E. (1996). Protease inhibitors: novel therapeutic application and development. Trends Biotechnol. 14(11), 409-412.
19. Kabsch, W. and Sander, C. (1983). Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22(12), 2577-2637.
20. Kempf, D. J. and Sham, H. L. (1996). HIV protease inhibitors. Curr. Pharm. Des. 2(2), 225-246.
21. Kim, J. L., Morgenstern, K. A., Lin, C., Fox, T., Dwyer, M. D., Landro, J. A., Chambers, S. P., Markland, W., Lepre, C. A., O'Malley, E. T., Harbeson, S. L., Rice, C. M., Murcko, M. A., Caron, P. R. and Thomson, J. A. (1996). Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87(2), 343-355.
22. Kim, T. W., Pettingell, W. H., Jung, Y. K., Kovacs, D. M. and Tanzi, R. E. (1997). Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277(5324), 373-376.
23. Kreutter, K., Steinmetz, A. C., Liang, T. C., Prorok, M., Abeles, R. H. and Ringe, D. (1994). Three-dimensional structure of chymotrypsin inactivated with (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane: implications for the mechanism of inactivation of serine proteases by chloroketones. Biochemistry 33(46), 13792-13800.
24. Li, Z., Chen, X., Davidson, E., Zwang, O., Mendis, C., Ring, C. S., Roush, W. R., Fegley, G., Li, R., Rosenthal, P. J., Lee, G. K., Kenyon, G. L., Kuntz, I. D. and Cohen, F. E. (1994). Antimalarial drug development using models of enzyme structure. Chem. Biol. 1(1), 31-37.
25. Love, R. A., Parge, H. E., Wickersham, J. A., Hostomsky, Z., Habuka, N., Moomaw, E. W., Adachi, T. and Hostomska, Z. (1996). The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 87(2), 331-342.
26. March, D. R. and Fairlie, D. P. (1996). Designing New Antiviral Drugs for AIDS: HIV-1 Protease and its Inhibitors (Wise, R., Ed.), Landes, Austin, TX.
27. Poorman, R. A., Tomasselli, A. G., Heinrikson, R. L. and Kezdy, F. J. (1991). A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J. Biol. Chem. 266(22), 14554-14561.
28. Richardson, J. S. (1981). The anatomy and taxonomy of protein structure. Adv. Protein Chem. 34, 167-339.
29. Selkoe, D. J. (1997). Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275(5300), 630-631.
30. Shieh, H. S., Kurumbail, R. G., Stevens, A. M., Stegeman, R. A., Sturman, E. J., Pak, J. Y., Wittwer, A. J., Palmier, M. O., Wiegand, R. C., Holwerda, B. C. and Stallings, W. C. (1996). Three-dimensional structure of human cytomegalovirus protease. Nature 383(6597), 279-282.
31. Silva, A. M., Lee, A. Y., Gulnik, S. V., Maier, P., Collins, J., Bhat, T. N., Collins, P. J., Cachau, R. E., Luker, K. E., Gluzman, I. Y., Francis, S. E., Oksman, A., Goldberg, D. E. and Erickson, J. W. (1996). Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc. Natl Acad. Sci. USA 93(19), 10034-10039.
32. Steinmetz, A. C., Demuth, H. U. and Ringe, D. (1994). Inactivation of subtilisin Carlsberg by N-((tert-butoxycarbonyl)alanylprolylphenylalanyl)-O-benzoylhydroxyl-amine: formation of a covalent enzyme-inhibitor linkage in the form of a carbamate derivative. Biochemistry 33(34), 10535-10544.
33. Stubbs, M. T. and Bode, W. (1993). A player of many parts: the spotlight falls on thrombin's structure. Thromb. Res. 69(1), 1-58.
34. Stubbs, M. T., Laber, B., Bode, W., Huber, R., Jerala, R., Lenarcic, B. and Turk, V. (1990). The refined 2.4Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. Embo J. 9(6), 1939-1947.
35. Sussman, J. L., Lin, D., Jiang, J., Manning, N. O., Prilusky, J., Ritter, O. and Abola, E. E. (1998). Protein data bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Cryst. D54, 1078-1084.
36. Swain, A. L., Miller, M. M., Green, J., Rich, D. H., Schneider, J., Kent, S. B. and Wlodawer, A. (1990). X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. Proc. Natl Acad. Sci. USA 87(22), 8805-8809.
37. Tanaka, R. D., Clark, J. M., Warne, R. L., Abraham, W. M. and Moore, W. R. (1995). Mast cell tryptase: a new target for therapeutic intervention in asthma. Int. Arch. Allergy Immunol. 107(1-3), 408-9.
38. Tomasseli, A. G. and Heinrikson, R. L. (1994). Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates. Meth. Enzymol. 241, 279-301.
39. Tomaszek, T. A., Jr., Moore, M. L., Strickler, J. E., Sanchez, R. L., Dixon, J. S., Metcalf, B. W., Hassell, A., Dreyer, G. B., Brooks, I., Debouck, C. and Meek, T. D. (1992). Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease. Biochemistry 31(42), 10153-10168.
40. West, M. L. and Fairlie, D. P. (1995). Targeting HIV-1 protease: a test of drug-design methodologies. Trends Pharmac. Sci. 16(2), 67-75.